Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis
1 clinical trials · Condition
◉ Watch Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis
| Record | Firm | Date |
|---|---|---|
| Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age (NCT07207408) | Dynavax Technologies Corporation | 2025-09-11 |
Track Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis automatically
Every clearance here is in the API, with alerts when new ones post.